Status:
COMPLETED
Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
Lead Sponsor:
University of Cincinnati
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
4-6 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of two medications--clonidine and methylphenidate--alone or in combination to treat attention deficit hyperactivity disorder in childre...
Detailed Description
Attention deficit hyperactivity disorder (ADHD) is a disease characterized by one or more symptoms of hyperactivity, impulsivity, or inattention that interfere with school, home, work, or social setti...
Eligibility Criteria
Inclusion
- Child with ADHD
- Child ages 4 through 6
- Child attending a structured preschool or daycare
Exclusion
- Presence of a tic disorder of any kind or a known active heart disease for which it would be unsafe to use the study drugs
- Presence of pervasive developmental disorder, autism, mental retardation, or serious psychiatric illness
- Child not attending a structured preschool or daycare
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00414921
Start Date
September 1 2003
End Date
June 1 2007
Last Update
May 21 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center, Department of Neurology, 919 Westfall Road, Building C
Rochester, New York, United States, 14618
2
University of Cincinnati, Department of Psychiatry, 231 Albert Sabin Way, M: 0559
Cincinnati, Ohio, United States, 45267-0559
3
Western Psychiatric Institute and Clinic, ADD Program, 3811 Ohara Street
Pittsburgh, Pennsylvania, United States, 15213